M T Lotze Selected Research

M T Lotze Research Topics

Disease

31	Neoplasms (Cancer) 10/2016 - 02/2000
4	Glioma (Gliomas) 08/2001 - 03/2000
3	Melanoma (Melanoma, Malignant) 12/2019 - 02/2000
3	Pancreatic Neoplasms (Pancreatic Cancer) 06/2015 - 01/2005
3	Gliosarcoma 08/2001 - 05/2000
3	Neoplasm Metastasis (Metastasis) 04/2001 - 02/2000
3	Central Nervous System Neoplasms 03/2001 - 03/2000
2	Leukemia 03/2015 - 01/2011
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2001 - 04/2000
2	Neuroblastoma 08/2001 - 01/2001
1	Hyperglycemia 10/2016
1	Lymphoma (Lymphomas) 10/2016
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2016
1	Atrophy 05/2015
1	Cognitive Dysfunction 05/2015
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 05/2015
1	Carcinogenesis 04/2011
1	Inflammation (Inflammations) 04/2010
1	Chronic Pancreatitis 01/2005
1	Experimental Melanoma 10/2001
1	Fibrosarcoma 10/2001
1	Breast Neoplasms (Breast Cancer) 01/2001
1	Nasopharyngeal Carcinoma 01/2001
1	Pancytopenia 01/2001
1	Sarcoma (Soft Tissue Sarcoma) 09/2000
1	Prostatic Neoplasms (Prostate Cancer) 08/2000

Drug/Important Bio-Agent (IBA)

8	Interleukin-12 (IL 12)IBA 08/2001 - 02/2000
7	CytokinesIBA 01/2005 - 02/2000
6	Interleukin-2 (IL2)IBA 12/2019 - 02/2000
6	Proteins (Proteins, Gene)FDA Link 05/2015 - 02/2000
5	Receptor for Advanced Glycation End ProductsIBA 06/2015 - 04/2010
5	Interleukin-4 (Interleukin 4)IBA 08/2001 - 03/2000
4	HMGB1 Protein (HMG1)IBA 01/2014 - 04/2010
3	DNA (Deoxyribonucleic Acid)IBA 06/2015 - 04/2000
3	LigandsIBA 01/2014 - 04/2000
3	Peptides (Polypeptides)IBA 10/2001 - 02/2000
3	Cancer VaccinesIBA 04/2001 - 03/2000
2	Biomarkers (Surrogate Marker)IBA 05/2015 - 01/2005
2	Paclitaxel (Taxol)FDA LinkGeneric 09/2010 - 04/2000
2	NF-kappa B (NF-kB)IBA 04/2010 - 10/2001
2	Interleukin-18 (Interleukin 18)IBA 11/2002 - 09/2000
2	AntigensIBA 08/2001 - 03/2001
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2001 - 04/2000
2	VaccinesIBA 04/2001 - 03/2000
2	InterleukinsIBA 09/2000 - 02/2000
1	Immune Checkpoint InhibitorsIBA 12/2019
1	copanlisibIBA 10/2016
1	Class I Phosphatidylinositol 3-KinasesIBA 10/2016
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2016
1	Histones (Histone)IBA 06/2015
1	Amyloid (Amyloid Fibrils)IBA 05/2015
1	LipidsIBA 05/2015
1	Biological ProductsIBA 05/2015
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 03/2015
1	Hypoxia-Inducible Factor 1IBA 10/2014
1	Adenosine Triphosphate (ATP)IBA 01/2014
1	Death Domain ReceptorsIBA 04/2011
1	Beclin-1IBA 04/2011
1	Pharmaceutical PreparationsIBA 01/2011
1	AntibodiesIBA 01/2011
1	Intercalating AgentsIBA 09/2010
1	Toll-Like Receptor 4IBA 09/2010
1	ethyl pyruvateIBA 09/2010
1	Alkylating AgentsIBA 09/2010
1	TubulinIBA 09/2010
1	Small Interfering RNA (siRNA)IBA 09/2010
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2010
1	Antineoplastic Agents (Antineoplastics)IBA 09/2010
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2010
1	Melphalan (Alkeran)FDA LinkGeneric 09/2010
1	CarcinogensIBA 04/2010
1	ChemokinesIBA 01/2005
1	RV 538 (PDMP)IBA 10/2001
1	ceramide glucosyltransferaseIBA 10/2001
1	Cycloserine (Seromycin)FDA Link 10/2001
1	Phorbol EstersIBA 10/2001
1	N-oleoylethanolamineIBA 10/2001
1	CeramidesIBA 10/2001
1	Interleukin-10 (Interleukin 10)IBA 10/2001
1	Acid CeramidaseIBA 10/2001
1	Interferon-alpha (Interferon Alfa)IBA 08/2001
1	Interferon-gamma (Interferon, gamma)IBA 08/2001
1	Neoplasm Antigens (Tumor Antigens)IBA 08/2001
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2001
1	Monoclonal AntibodiesIBA 04/2001
1	S100 Calcium Binding Protein A6IBA 03/2001
1	Complementary DNA (cDNA)IBA 03/2001
1	monoaminocarboxydihydroboraneIBA 01/2001
1	GangliosidesIBA 01/2001
1	Interleukin-15 (Interleukin 15)IBA 08/2000
1	Apoptosis Regulatory ProteinsIBA 08/2000
1	CD40 Ligand (CD40L)IBA 08/2000
1	salicylhydroxamic acid (SHAM)IBA 05/2000

Therapy/Procedure

12	Therapeutics 12/2019 - 02/2000
6	Immunotherapy 08/2001 - 02/2000
4	Drug Therapy (Chemotherapy) 12/2019 - 01/2011
1	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2019
1	Injections 04/2001
1	Intra-Arterial Injections 01/2001
1	Immunomodulation 05/2000